GlassScriptPhysician profile
Kallye Baggett
NPI 1710681283
$3,156.47
in general payments reported to CMS, 2019-2025
8 companies · $2,557 in 2025
The $2,557 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $101 · 2024: $499 · 2025: $2,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310 · Education: $1,137 · Travel and Lodging: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,309.62 |
| Education | $1,137.01 |
| Travel and Lodging | $709.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,709.84 | 2025 | |
| Baxter Healthcare | $581.88 | 2024-2025 | Tisseel, Perclot |
| Integra Lifesciences Corporation | $227.89 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $188.33 | 2024-2025 | Signia |
| Medical Device Business Services, INC. | $137.01 | 2024 | |
| Innovation Technologies INC | $136.12 | 2025 | Irrisept |
| Polynovo North America LLC | $100.85 | 2023 | |
| Zimmer Biomet Holdings, INC. | $74.55 | 2025 | Ribfix Blu Advantage |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kallye Baggett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.